| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/02/2014 | US20140004117 B-cell reduction using cd37-specific and cd20-specific binding molecules |
| 01/02/2014 | US20140004116 Methods of preventing or treating pain using anti-ngf antibodies |
| 01/02/2014 | US20140004114 Stable and soluble antibodies inhibiting vegf |
| 01/02/2014 | US20140004112 Therapeutic Peptides |
| 01/02/2014 | US20140004110 Anti cd37 antibodies |
| 01/02/2014 | US20140004109 Methods Of Reducing Eosinophil Levels |
| 01/02/2014 | US20140004107 St2 antigen binding proteins |
| 01/02/2014 | US20140004103 Method of treating malignant mesothelioma |
| 01/02/2014 | US20140004095 Albumin fusion proteins |
| 01/02/2014 | US20140004078 Immunoconjugates with an Intracellularly-Cleavable Linkage |
| 01/02/2014 | US20140004037 Stabilization of the anti-cd20 antibody rituximab |
| 01/01/2014 | EP2680004A2 Compositions and methods for detecting cancer |
| 01/01/2014 | EP2679681A1 Fc riib-specific fc antibody |
| 01/01/2014 | EP2679600A1 Anti-FGFR3 antibodies and methods using same |
| 01/01/2014 | EP2679599A1 Antibodies directed to Angiopoietin-1 and Angiopoietin-2 and use thereof |
| 01/01/2014 | EP2679241A1 Assay for benzylpiperazines and metabolites |
| 01/01/2014 | EP2679232A1 Composition for use in Mycobacteria vaccination |
| 01/01/2014 | EP2678360A1 Methods for treating and diagnosing disease |
| 01/01/2014 | EP2678359A2 Combination therapies comprising anti-erbb3 agents |
| 01/01/2014 | EP2678358A1 Antibodies against human il33r and uses thereof |
| 01/01/2014 | EP2678357A1 Method of production of sialylated antibodies |
| 01/01/2014 | EP2678356A1 Method for treating liver inflammation, fibrosis and non-alcoholic steatohepatitis. |
| 01/01/2014 | EP2678355A1 Novel superactive il-33 fragments, and uses thereof |
| 01/01/2014 | EP2678033A2 Treatment and prevention of malaria |
| 01/01/2014 | EP2678026A1 Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders |
| 01/01/2014 | CN103492583A Dual variable domain immunoglobulins and uses thereof |
| 01/01/2014 | CN103492575A Nav1.7 knockout mice and uses thereof |
| 01/01/2014 | CN103492565A FcgRIIb-specific Fc antibody |
| 01/01/2014 | CN103492419A Binding molecules capable of neutralizing the rabies virus, and uses thereof |
| 01/01/2014 | CN103492418A Antibodies against kidney associated antigen 1 and antigen binding fragments thereof |
| 01/01/2014 | CN103492417A Tumor specific antibodies and uses therefor |
| 01/01/2014 | CN103492416A Anti- IL-1R1 inhibitors for use in cancer |
| 01/01/2014 | CN103492415A Antibody to signal peptide of amyloid precursor protein |
| 01/01/2014 | CN103492414A Anti-HEPCIDIN antibodies and uses thereof |
| 01/01/2014 | CN103492413A Anti-TACE antibody molecules and their uses |
| 01/01/2014 | CN103491979A Malaria vaccines based on pre-erythrocytic antigens from p. falciparum |
| 01/01/2014 | CN103484438A High-glyphosate-tolerance EPSP synthase (5-enolpyruvylshikimate-3-phosphate synthase), and coding gene and application thereof |
| 01/01/2014 | CN103484434A Hybridoma cell strain and applications thereof |
| 01/01/2014 | CN103483451A Antibody labeled porphyrin iso-indole free radical compound and synthetic method thereof |
| 01/01/2014 | CN103483450A Immunoassay method for human cxcl1 protein |
| 01/01/2014 | CN103483449A Two ScFv (Single Chain Variable Fragment ) antibodies, encoding genes and application thereof for preparing preparation for treating or preventing infectious bursal disease of chicken |
| 01/01/2014 | CN103483448A Antibody for specific binding with highly-pathogenic avian influenza virus |
| 01/01/2014 | CN103483447A Broad spectrum monoclonal antibodies or antigen binding fragments thereof of anti-HPV L1 protein, and applications thereof |
| 01/01/2014 | CN103483446A Broad spectrum neutralization monoclonal antibodies or antigen binding fragments thereof of anti-HPV L2 protein, and applications thereof |
| 01/01/2014 | CN103483445A Preparation methods and applications of benzylpenicilloic acid artificial antigen and benzylpenicilloic acid artificial antibody |
| 01/01/2014 | CN103483444A Antibody for detecting and determining berberine, and method and kit thereof |
| 01/01/2014 | CN103483441A Rhesus monkey NY-ESO-1 protein, coding gene, and applications thereof |
| 01/01/2014 | CN103483431A Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications |
| 01/01/2014 | CN103483421A Polypeptide used for treating HBV infection and related diseases, and antibodies thereof |
| 01/01/2014 | CN102336834B Fully human TNFalpha-Fab antibody and its PEG antibody |
| 01/01/2014 | CN102297967B Surface plasma resonance detecting method for PVY/CMV (Potato Virus Y/Cucumber Mosaic Virus) |
| 01/01/2014 | CN102264394B Lipidated imidazoquinoline derivatives |
| 01/01/2014 | CN102239179B Integrin peptide, anti-cd 18 beta A antibody for treatment of endotoxin-mediated pro-inflammatory responses and the use |
| 01/01/2014 | CN102180965B Carbamazepine immunogen, anti-carbamazepine specific antibody, detection reagent and detection kit |
| 01/01/2014 | CN101809153B Factor involved in latent infection with herpesvirus, and use thereof |
| 01/01/2014 | CN101454025B 抗体纯化 Antibody Purification |
| 12/31/2013 | USRE44681 Compositions and methods for inhibiting growth of SMAD4-deficient cancers |
| 12/31/2013 | US8618276 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues |
| 12/31/2013 | US8618265 Haptens, hapten conjugates, compositions thereof and method for their preparation and use |
| 12/31/2013 | US8618264 Anti-CD147 antibodies, methods and uses |
| 12/31/2013 | US8618263 Antibodies against tissue factor pathway inhibitor (TFPI) |
| 12/31/2013 | US8618262 Monoclonal antibodies against dendritic cell receptor |
| 12/31/2013 | US8618261 Immuno-based botulinum toxin serotype A activity assays |
| 12/31/2013 | US8618260 Tyrosine, serine and threonine phosphorylation sites |
| 12/31/2013 | US8618254 Inhibition of AXL signaling in anti-metastatic therapy |
| 12/31/2013 | US8618252 Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related thereto |
| 12/31/2013 | US8618251 Fc mutants |
| 12/31/2013 | US8618248 Phosphopeptide compositions and anti-phosphopeptide antibody compositions and methods of detecting phosphorylated peptides |
| 12/31/2013 | US8618247 Peptide, use of the peptide, method for the production of the peptide, solid support having the peptide immobilized thereon, and method for production of the solid support |
| 12/31/2013 | US8618053 FGF21 mutants multimers and uses thereof |
| 12/31/2013 | US8617894 Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and uses |
| 12/31/2013 | US8617880 Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof |
| 12/31/2013 | US8617846 Tumor-specific recognition molecules |
| 12/31/2013 | US8617833 Estrogen receptors and methods of use |
| 12/31/2013 | US8617830 Method for identifying lineage-related antibodies |
| 12/31/2013 | US8617829 Humanized antibodies specific for amino acid sequence RGD of an extracellular matrix protein and the uses thereof |
| 12/31/2013 | US8617828 Glutathione S-transferase omega 1 wild type specific antibody |
| 12/31/2013 | US8617822 Method of inhibiting binding or activity of MIF by administering a MIF antagonist |
| 12/31/2013 | US8617557 Antibody fusion with IL-12 proteins with disrupted heparin-binding activity |
| 12/31/2013 | US8617555 Pharmaceutical compositions comprising activated-potentiated antibodies to human insulin receptor and endothelial nitric oxide (NO) synthase |
| 12/31/2013 | US8617554 Anti-human CD52 immunoglobulins |
| 12/31/2013 | US8617553 Use of goat serum for veterinary treatment |
| 12/31/2013 | US8617552 IL-17 antibodies |
| 12/31/2013 | US8617551 Methods of diagnosing pancreatic inflammation by using chemokine PANEC-1 antibodies |
| 12/31/2013 | US8617549 Bispecific nanobodies as a therapeutic for alzheimer's disease |
| 12/31/2013 | US8617521 Phage antibodies to radiation-inducible neoantigens |
| 12/31/2013 | US8617514 Tumor-targeted nanodelivery systems to improve early MRI detection of cancer |
| 12/31/2013 | CA2722364C Melanoma antigens |
| 12/31/2013 | CA2548454C Medicament comprising recombinant antibody against chemokine receptor ccr4 |
| 12/31/2013 | CA2523001C Therapeutic use of anti-cs1 antibodies |
| 12/31/2013 | CA2485847C Glucan-based vaccines |
| 12/31/2013 | CA2246768C Uses of gdnf and gdnf receptor |
| 12/27/2013 | WO2013192596A2 Antigen binding proteins that bind ccr2 |
| 12/27/2013 | WO2013192550A2 Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof |
| 12/27/2013 | WO2013192546A1 Activatable antibodies having non-binding steric moieties and mehtods of using the same |
| 12/27/2013 | WO2013192240A2 Compositions and methods of inhibiting masp-1 and/or masp-2 and/or masp-3 for the treatment of various diseases and disorders |
| 12/27/2013 | WO2013191982A2 Antigen binding proteins that bind igf1r |
| 12/27/2013 | WO2013191199A1 Method for improving protein rapidly |
| 12/27/2013 | WO2013191166A1 IgE PEPTIDE VACCINE |
| 12/27/2013 | WO2013191146A1 Kit for diagnosing malignant melanoma |